-- U.S. RESEARCH ROUNDUP-BlackBerry, Biomarin Pharmaceutical, NU Skin 
-- 
-- Tue Mar 25, 2014 02:12AM EDT
-- None



March 25 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biomarin Pharmaceutical and BlackBerry, on Tuesday.

HIGHLIGHTS * Biomarin Pharmaceutical <BMRN.O>: Goldman Sachs cuts to neutral from buy * Blackberry <BBRY.O>: BMO raises price target to $8 from $7; rating market perform * ARM Holdings <ARMH.O>: Canaccord Genuity raises target price to $60 from $55; rating buy  Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order. See bottom of the table for sector changes.   * ARM Holdings <ARMH.O>: Canaccord Genuity raises target price to $60 from $55; rating buy * Biomarin Pharmaceutical <BMRN.O>: Goldman Sachs cuts to neutral from buy * Biomarin Pharmaceutical <BMRN.O>: Goldman Sachs removes from Americas Buy List * Blackberry <BBRY.O>: BMO raises price target to $8 from $7; rating market perform * Columbia Banking System <COLB.O>: D. A. Davidson cuts to neutral from buy  * Computer Sciences <CSC.N>: SunTrust Robinson starts with neutral; price target of $68 * Convergys Corp <CVG.N>: SunTrust Robinson starts with buy rating; price target of $26 * Exa Corp <EXA.O>: Canaccord Genuity raises target price to $17 from $16; rating buy * Farmers Capital Bank <FFKT.O>: KBW raises to outperform from market perform  * Farmers Capital Bank <FFKT.O>: KBW raises target price to $26 from $22 * Luxfer Holdings <LXFR.N>: Oppenheimer raises target price by $3 to $25; rating outperform * Nabors Industries <NBR.N>: RBC raises target price to $29 from $25; rating outperform * NPS Pharmaceuticals <NPSP.O>: Goldman Sachs starts with buy rating; price target of $45 * NU Skin Enterprises <NUS.N>: Canaccord Genuity raises target to $93 from $78; rating hold * Precision Drilling <PDS.N>: Jefferies raises price target to $14 from $13; rating buy